These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 38018880

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Ceftolozane and Tazobactam in Human Plasma Microsamples.
    Conti M, Giorgi B, Gatti M, Viale P, Pea F.
    Ther Drug Monit; 2024 Aug 06. PubMed ID: 39115870
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A validated method for the quantification of fosfomycin on dried plasma spots by HPLC-MS/MS: application to a pilot pharmacokinetic study in humans.
    Parker SL, Lipman J, Dimopoulos G, Roberts JA, Wallis SC.
    J Pharm Biomed Anal; 2015 Nov 10; 115():509-14. PubMed ID: 26299527
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug monitoring and pharmacokinetic studies.
    Llopis B, Bleibtreu A, Schlemmer D, Robidou P, Paccoud O, Tissot N, Noé G, Junot H, Luyt CÉ, Funck-Brentano C, Zahr N.
    Clin Chem Lab Med; 2021 Oct 26; 59(11):1800-1810. PubMed ID: 34243226
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
    Müller C, Gehlen D, Blaich C, Prozeller D, Liss B, Streichert T, Wiesen MHJ.
    Ther Drug Monit; 2017 Oct 26; 39(5):505-513. PubMed ID: 28742650
    [Abstract] [Full Text] [Related]

  • 11. A fast and sensitive LC-MS/MS method for the quantification of fosfomycin in human urine and plasma using one sample preparation method and HILIC chromatography.
    Wijma RA, Bahmany S, Wilms EB, van Gelder T, Mouton JW, Koch BCP.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep 01; 1061-1062():263-269. PubMed ID: 28759841
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A quantitative method for the analysis of total and unbound concentrations of amoxicillin, ampicillin, ceftazidime, ceftriaxone, ertapenem, fosfomycin and penicillin G in human plasma with liquid chromatography-tandem mass spectrometry assay.
    van der Veer MAA, van der Meer-Vos M, de Haan TR, Franken LGW, Bijleveld YA, Mathôt RAA.
    Biomed Chromatogr; 2024 Oct 01; 38(10):e5956. PubMed ID: 39090778
    [Abstract] [Full Text] [Related]

  • 14. Quantitative Determination of Fosfomycin in 10 μL of Plasma and Dialysate by Hydrophilic Interaction Liquid Chromatography Electrospray Ionization Mass Spectrometry.
    Shopova T, Hüppe T, Wolf B, Sessler DI, Volk T, Groesdonk HV, Kreuer S, Maurer F.
    J Chromatogr Sci; 2021 Jan 14; 59(2):165-174. PubMed ID: 33302294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A simple LC-MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: application to a pilot pharmacokinetic study in humans.
    Parker SL, Lipman J, Roberts JA, Wallis SC.
    J Pharm Biomed Anal; 2015 Feb 14; 105():39-45. PubMed ID: 25527980
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development and validation of a LC-MS/MS method for quantitation of fosfomycin - Application to in vitro antimicrobial resistance study using hollow-fiber infection model.
    Gandhi A, Matta M, Garimella N, Zere T, Weaver J.
    Biomed Chromatogr; 2018 Jun 14; 32(6):e4214. PubMed ID: 29461629
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.